These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 9527506)

  • 1. Effects of a psychostimulant drug sydnocarb on rat brain dopaminergic transmission in vivo.
    Gainetdinov RR; Sotnikova TD; Grekhova TV; Rayevsky KS
    Eur J Pharmacol; 1997 Dec; 340(1):53-8. PubMed ID: 9527506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amphetamine and sydnocarb on dopamine release and free radical generation in rat striatum.
    Afanas'ev II; Anderzhanova EA; Kudrin VS; Rayevsky KS
    Pharmacol Biochem Behav; 2001; 69(3-4):653-8. PubMed ID: 11509228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis.
    Nomikos GG; Damsma G; Wenkstern D; Fibiger HC
    Neuropsychopharmacology; 1989 Dec; 2(4):273-9. PubMed ID: 2482026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of d-amphetamine and sydnocarb on the extracellular level of dopamine, 3,4-dihydroxyphenylacetic acid, and hydroxyl radicals generation in rat striatum.
    Anderzhanova EA; Afanas'ev II; Kudrin VS; Rayevsky KS
    Ann N Y Acad Sci; 2000 Sep; 914():137-45. PubMed ID: 11085316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral, toxic, and neurochemical effects of sydnocarb, a novel psychomotor stimulant: comparisons with methamphetamine.
    Witkin JM; Savtchenko N; Mashkovsky M; Beekman M; Munzar P; Gasior M; Goldberg SR; Ungard JT; Kim J; Shippenberg T; Chefer V
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1298-310. PubMed ID: 10027871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats.
    Kääriäinen TM; Lehtonen M; Forsberg MM; Savolainen J; Käenmäki M; Männistö PT
    Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):50-8. PubMed ID: 17971064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined effect of amphetamine and midantan on the dopaminergic transmission in the striatum of freely moving rats].
    Afanas'ev II; Dvorkina ML; Raevskiĭ KS
    Eksp Klin Farmakol; 2003; 66(1):3-7. PubMed ID: 12683071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats.
    Narita M; Takagi M; Aoki K; Kuzumaki N; Suzuki T
    J Neurochem; 2003 Jul; 86(2):273-82. PubMed ID: 12871568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine-induced dopamine levels in the rat striatum and nucleus accumbens are not affected by muscarinic antagonism.
    Gray AM; Connick JH
    Eur J Pharmacol; 1998 Dec; 362(2-3):127-36. PubMed ID: 9874162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
    Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
    J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats.
    Invernizzi R; Morali F; Pozzi L; Samanin R
    Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons between bupropion and dexamphetamine in a range of in vivo tests exploring dopaminergic transmission.
    Bredeloux P; Dubuc I; Costentin J
    Br J Pharmacol; 2007 Mar; 150(6):711-9. PubMed ID: 17293887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of ambient room temperature has differential effects on MDMA-induced 5-HT and dopamine release in striatum and nucleus accumbens of rats.
    O'Shea E; Escobedo I; Orio L; Sanchez V; Navarro M; Green AR; Colado MI
    Neuropsychopharmacology; 2005 Jul; 30(7):1312-23. PubMed ID: 15688085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens.
    Abekawa T; Ohmori T; Koyama T
    Brain Res; 1994 Apr; 643(1-2):276-81. PubMed ID: 7518327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine in the basal ganglia and benzodiazepine-induced sedation.
    Brose N; O'Neill RD; Boutelle MG; Fillenz M
    Neuropharmacology; 1988 Jun; 27(6):589-95. PubMed ID: 3419542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an anxiogenic benzodiazepine receptor ligand on motor activity and dopamine release in nucleus accumbens and striatum in the rat.
    Brose N; O'Neill RD; Boutelle MG; Anderson SM; Fillenz M
    J Neurosci; 1987 Sep; 7(9):2917-26. PubMed ID: 3040928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis.
    Hara S; Mukai T; Kurosaki K; Kuriiwa F; Endo T
    Arch Toxicol; 2002 Oct; 76(10):596-605. PubMed ID: 12373456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine release and metabolism in nucleus accumbens and striatum of morphine-tolerant and nontolerant rats.
    Johnson DW; Glick SD
    Pharmacol Biochem Behav; 1993 Oct; 46(2):341-7. PubMed ID: 8265688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in effects of Ca2+ channel antagonists on dopamine metabolism in the limbic and extrapyramidal dopaminergic structures.
    Antkiewicz-Michaluk L; Romańska I; Vetulani J
    Psychopharmacology (Berl); 1996 Nov; 128(1):39-44. PubMed ID: 8944404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Microdialysis study of tolcapone effect during blockage of neuronal dopamine reuptake caused by GBR-12909].
    Budygin EA; Gaĭnetdinov RR; Raevskiĭ KS; Li IH; Mannisto PT
    Eksp Klin Farmakol; 1997; 60(5):8-10. PubMed ID: 9483396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.